University of South Florida

Initial public offerings by biopharmaceutical companies are back on an above-average track after eight firms went public in the US during the week of 14 to 18 June, raising $1.46bn combined, including

[Johnson & Johnson Innovation - JLABS] has been launching its JLABS sites within biotechnology hubs such as Boston, San Diego and San Francisco since 2012, but it chose Philadelphia as the site for it

PHARMACEUTICALS Agilis Biotherapeutics LLC National Taiwan University National Taiwan University Hospital Agilis licenses NTU 's AADC deficiency gene therapy Gene therapy start-up Agilis Biothe

IN VITRO DIAGNOSTICS Biomecite Diagnostics LLC University of Maryland University of Maryland, Baltimore Biomecite gets option to GI-related IP from Univ. of MD, Baltimore University of Marylan